Concepedia

Kah Fei Wan

KF

Statistics

Publications

21

Citations

1.1K

H-Index

18

Active since

2001

Affiliations

Novartis (Singapore)(Current)

Novartis (Switzerland)

Agency for Science, Technology and Research

Institute of Molecular and Cell Biology

Novartis (United States)

Kah Fei Wan is an author at Novartis (Singapore) specializing in life sciences, drug discovery, and molecular biology.

ORCID

Publications per year

2001–2023

21

Publications

21

Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling

Siew Pheng Lim, Christian G. Noble, Cheah C. Seh et al. · PLoS Pathogens · 2016 · 181 citations · Full text

, , +17

Discovery of Dengue Virus NS4B Inhibitors

Qing-Yin Wang, Hongping Dong, Bin Zou et al. · Journal of Virology · 2015 · 103 citations · Full text

, , +17

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

Stephanie Moquin, Oliver Simon, Ratna Karuna et al. · Science Translational Medicine · 2021 · 93 citations

, , +17

The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase

David Estoppey, Chia Min Lee, Marco Janoschke et al. · Cell Reports · 2017 · 79 citations · Full text

, , +16

Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools

Jaclyn S. Long, Peter I. Darroch, Kah Fei Wan et al. · Biochemical Journal · 2005 · 72 citations · Full text

, , +17

1–5 of 21